TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in patients' knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Left ventricular native stroke volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: GDMT optimization score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of adverse events per patient
Endpoint domain: Adverse events/effects
Primary endpoint: throwing accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: throwing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: throwing force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Declines in MAT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participant preference for web-based intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Regression in DRSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear film production improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in eye dryness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral Load (VL) rebound time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Viral Load (VL) after VHM treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facial skin remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skin firmness improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 10-m Walk Test at Comfortable Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of PI for inpatient treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Processes of change concerning depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Processes of change concerning physical activity (PA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean daily OCS dosage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exacerbation rates
Endpoint domain: Adverse events/effects
Primary endpoint: early recovery in pain and muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food intake during meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of PRL in the vitreous
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Inhibition of endothelial cell proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: G2+ nausea improvement
Endpoint domain: Adverse events/effects
Primary endpoint: G2+ sensory neuropathy worsening
Endpoint domain: Adverse events/effects
Primary endpoint: G2+ pain decrease
Endpoint domain: Adverse events/effects
Primary endpoint: MSQ RFR scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Concentration of volatile sulfur compounds (VSC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1RM (One Repetition Maximum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sprint time (10m and 30m)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative visual analog scale (VAS) score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Correct identification of bag contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of HTGW+ phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anastomotic complications requiring intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Time in Tight Glycaemic Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nocturnal Time Below Range (TBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Flow rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean and peak pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of questions answered correctly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leg volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GAIS results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean difference time for Trail B Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GIP secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean T2 values of intervertebral discs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frontal theta heartbeat-evoked brain responses changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Amplitude of submental and infrahyoid muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geniohyoid muscle movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life expectancy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: treatment intent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: terminal illness acknowledgment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Salivary LDH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurable levels of Dex-P
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dexamethasone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative air–bone gap (ABG) within 20 dB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage reduction in wound size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histological parameters of wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher levels of BSAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Helbing angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: femorotibial angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Fick angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Detection of cis isomer in processed plasma samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mGCC thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RNFLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (Social Domain)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Participant-reported symptom resolution at week 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative bronchial complications
Endpoint domain: Adverse events/effects
Primary endpoint: Prevent decompensation in patients with compensated cirrhosis
Endpoint domain: Mortality/survival
Primary endpoint: NSE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: WMS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cerebral hemodynamic indexes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased mobility of the spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SMQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight Concerns Scale (WCS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall awareness of stroke
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical knowledge and competencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disrupted nighttime sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: % of days with ≥ 4 hours of PAP use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use all nights (hours of PAP use)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAPapp use satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative pain measured by VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total meperidine dose required
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean changes in the visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quality efficiency rate
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Activity of daily living scale scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Self‐rating anxiety scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Requirement of hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative pain measured by Visual Analog Scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: threat assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive functioning improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average days without chemotherapy-induced nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life function scores according to the Functional Living Index - Emesis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of central catheter‐related bloodstream infection
Endpoint domain: Adverse events/effects
Primary endpoint: Mean ICDAS score increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable time of the block level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: sperm progressive motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sperm count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive recall hits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative recall hits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Food Addiction (FA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum height in the CMJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean power in the back squat test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscular endurance performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia severity index (ISI) scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: 25(OH)D3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cholecalciferol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MCP-1 response to stored RBC transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morbidity or mortality
Endpoint domain: Mortality/survival
Primary endpoint: maximal inspiratory training
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: quality of life (Minnesota Living with Heart Failure Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: thromboembolic disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mRC (modified Regeneration Criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aesthetic score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correct inhaler use on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of use rating for inhaler
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immediate readiness for use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost reduction per procedure
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical remission at 30-day follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical symptoms of pouchitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased microbial diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer loose stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fat mass increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fat-free leg mass decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1-year non-relapse mortality (NRM)
Endpoint domain: Mortality/survival
Primary endpoint: 3-year non-relapse mortality (NRM)
Endpoint domain: Mortality/survival
Primary endpoint: post-autoHCT progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: current week's mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: current week's step count
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: current week's sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quiz 2 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for ARS or combination with traditional lecture
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived helpfulness of ARS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SLRT performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of primary endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum rate of oxygen consumption during exercise (VO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in cigarettes per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in NNAL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reduction in carbon monoxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean set-up time
Endpoint domain: Surgical and medical procedures outcomes
Primary endpoint: Average annual savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete clearance of MC lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 30- and 90-day mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rate of kidney-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of serious kidney-related adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Full recovery of kidney function within 30 days after an acute kidney injury (AKI) event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement in facial papules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in frontotemporal hairline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in total scalp margins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4 count at ART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of dental pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: flexibility of hamstrings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Video submissions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improvement of abdominal pain or bowel gas after 24 h of GESD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in GGT levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pruritus frequency
Endpoint domain: Adverse events/effects
Primary endpoint: TP53 mutation frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mitotic age of normal breast epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of luminal progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Positive screening for postpartum depression (PPD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CDI recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: UCL repair length change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesion response after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of 18F-FLT PET for baseline HCC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean 18F-FLT PET uptake after TACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of renal outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Glycaemic response to glargine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment rate of pregnant women who smoke
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of all study components
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: VEINES-QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VEINES-Sym score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Frequency of glucose testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in HIV-1 DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma HIV-1 RNA levels <50 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Driving impairment at 1.5 hr post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: time of first request for analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid consumption in 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient satisfaction with pain relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain-related fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NACE (net adverse clinical events)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum concentrations of SHBG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Serum concentrations of total testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Experiencing blueness three or more days per week
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Posttest knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Communication skills success scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Out of pocket costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per IVF cycle
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reporting quality of PA programs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Day-28 ventilator-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 3D step height change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protective efficacy of SaLeish vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cerebral cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes